Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Agencies Working To Develop Faster Ebola Diagnostic Tests

VOA News: Better Ebola Tests Expected Within Months “…Health agencies agree there is an urgent need for innovative ways to provide rapid, sensitive, safe, and simple testing. WHO, Doctors Without Borders, and the private organization the Foundation of Innovative New Diagnostics are working with a number of companies to develop…

Private Financial Backing, Strong Coordination Can Help Eliminate NTDs

The Guardian: Pills, philanthropy, and parasitic worms Ellen Agler, chief executive, and Warren Lancaster, senior vice president of program, both at the End Fund “…The global movement to end NTDs has seen significant momentum in recent years. One of the most promising aspects of this is that new partners have…

FCAA Report Examines Philanthropic Funding For HIV/AIDS, Shows Decrease

Funders Concerned About AIDS (FCAA): Philanthropic Support to Address HIV/AIDS in 2013 The latest edition of this annual report from FCAA shows that “[f]unding to address HIV/AIDS from global private philanthropic institutions totaled $592 million in 2012, an 8% decrease from 2012, and the lowest level of funding since 2007”…

GlaxoSmithKline Again Tops ‘Access To Medicine Index’

New York Times: GlaxoSmithKline Leads In Getting Drugs to Poor “For the fourth time, GlaxoSmithKline has led all other pharmaceutical companies on an influential list ranking companies by how effectively they help the world’s poor get needed medicines. The list, the Access to Medicine Index, has been published every other…

Growing Global Vaccine Market Helping Spur Drug Companies To Pursue Ebola Vaccine

The New Yorker: The Race for an Ebola Vaccine “…So why this race to create an Ebola vaccine among Merck, GlaxoSmithKline, and Johnson & Johnson — three of the world’s biggest drug manufacturers? … [O]ver the past several years, companies have realized that the difficulties of making vaccines could be…

Merck Purchasing Rights To NewLink’s Experimental Ebola Vaccine

News outlets report on a deal between pharmaceutical companies Merck and NewLink to develop, test, and market a potential Ebola vaccine. NPR: Merck Partners With NewLink To Speed Up Work On Ebola Vaccine “[Monday] NewLink Genetics said it has made a deal with drugmaker Merck to research, develop, manufacture, and…

Experts Discuss Global Health Collaboration In Devex Google Hangout

Devex: The future of public, private sector, and NGO collaboration in global health “There’s a firm consensus among global health experts that collaboration between the public and private sectors and NGOs is crucial to address emerging global health issues. In this Google Hangout, Devex’s Michael Igoe reached out to representatives…